Search

everythinglearnresearchcommunity

for

Search:↓

Type 1 diabetes often occurs with other autoimmune diseases, and personalized treatment based on genetics can improve outcomes.

Thymic peptides can either promote or inhibit human hair growth.

A woman was the first known case to have both polycystic ovary syndrome and autoimmune polyglandular syndrome type 2, suggesting a need to check for both conditions in similar patients.

A woman's severe skin reaction was caused by an allergy to a skin treatment.

Thyroxine (T4) may help heal skin wounds by promoting new skin and blood vessel growth.

A specific gene mutation causes vitamin D resistance, but certain vitamin D analogs might help.

Sex hormones influence immune responses and may help treat diseases.

Glucocorticoid treatment improved symptoms in a girl with Satoyoshi disease.

Treg cells help repair and regenerate tissues by interacting with local cells.

No significant hormone differences found in postmenopausal women with androgenetic alopecia.

PTHrP and its receptor can control blood vessel growth and hair development in mouse skin.

Severe hypothyroidism can cause eyebrow hair loss, but improves with thyroid hormone treatment.

HPH-15, a new compound, effectively reduces skin fibrosis in experiments without causing harm.

Secukinumab treatment may cause HBV reactivation and hair discoloration.

A hidden autoimmune syndrome was found during a shock, showing thyroid, adrenal, and ovarian issues.

Certain proteins are significantly increased in the skin of people with hidradenitis suppurativa.

ADT-G may be a useful indicator of increased androgen levels in women with acne and can be lowered with certain birth control pills.

Removing both ovaries can treat increased testosterone and related symptoms in postmenopausal women with ovarian hyperthecosis.

Beta-trace protein may help diagnose and predict treatment response in certain nerve disorders.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

A3 antibody helps identify key cells in rat hair follicle development.

Nonimmunogenic forms of keratins K71 and K31 can delay and prevent alopecia areata.

Comprehensive screening for infections is crucial before starting JAK inhibitors in alopecia areata patients.

A specific type of immune cell plays a key role in causing alopecia areata and could be a target for treatment.

Early detection, prevention, and proper management can reduce TB-IRIS complications and deaths in HIV patients.

Increasing regulatory T cells may help treat alopecia areata by reducing autoimmunity and promoting hair growth.

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

Gender-affirming hormone treatments need better patient-focused outcome measurements and standardized data collection.

AR-27 E-Chol siRNA can effectively promote hair regrowth for androgenetic alopecia.